Watchlist Manager

Watchlist

Price: 14.78 CNY 0.27% Market Closed

Market Cap: ¥16.4B

J	Jinyu Bio-Technology Co Ltd SSE:600201	CN
P	PTL Enterprises Ltd NSE:PTL	IN
E	Emico Holdings Bhd KLSE:EMICO	MY

Balance Sheet

Currency: CNY

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	165	196	174	139	141	126	232	340	320	278	420	315	712	948	1 030	2 401	2 452	1 709	1 099	1 516	1 333	1 395	1 683	1 106
Cash	0	0	0	0	0	0	0	0	0	0	0	7	0	0	0	0	0	0	0	0	1 183	1 257	1 683	1 106
Cash Equivalents	165	196	174	139	141	126	232	340	320	278	420	308	712	948	1 030	2 401	2 452	1 709	1 099	1 516	150	139	0	0
Short-Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	673	640	184	47	37	37
Total Receivables	87	102	65	93	72	60	99	60	171	99	63	151	252	183	269	308	622	854	643	664	905	874	914	694
Accounts Receivables	29	54	46	53	46	42	74	43	93	76	52	125	155	172	249	263	466	767	576	606	729	763	857	633
Other Receivables	58	48	19	41	26	18	26	17	77	24	11	26	98	11	20	45	156	87	67	58	175	111	57	61
Inventory	224	220	394	304	338	237	373	362	480	750	794	889	157	217	222	229	231	313	245	351	318	333	322	295
Other Current Assets	22	17	11	101	73	136	184	106	28	46	46	51	40	20	22	283	815	837	35	17	22	31	59	60
Total Current Assets	497	534	644	638	625	560	888	868	999	1 173	1 322	1 407	1 162	1 369	1 543	3 220	4 119	3 713	2 694	3 187	2 761	2 681	3 016	2 191
PP&E Net	129	184	221	249	243	237	256	229	238	255	251	337	410	578	718	606	860	1 571	1 720	1 726	1 822	1 800	1 893	1 832
PP&E Gross	129	184	221	249	243	237	256	229	238	255	251	337	410	578	718	606	860	1 571	1 720	1 726	1 822	1 800	1 893	1 832
Accumulated Depreciation	71	93	105	105	125	139	174	208	237	216	245	238	256	305	357	394	414	455	514	640	772	894	1 034	1 157
Intangible Assets	33	33	32	39	56	54	69	64	64	62	58	56	59	62	98	270	354	481	520	577	649	669	729	653
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	146	131	134	95	29	11	8
Note Receivable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10	0	0	0	0	0	0
Long-Term Investments	103	62	61	68	62	90	70	68	85	82	79	62	60	59	155	206	277	288	415	557	1 166	1 123	1 125	1 927
Other Long-Term Assets	0	0	0	61	59	3	12	14	15	18	15	21	21	31	37	46	75	105	107	97	113	88	99	154
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	146	131	134	95	29	11	8
Total Assets	762 N/A	813 +7%	958 +18%	1 054 +10%	1 044 -1%	943 -10%	1 295 +37%	1 243 -4%	1 399 +13%	1 589 +14%	1 725 +9%	1 883 +9%	1 712 -9%	2 098 +23%	2 550 +22%	4 348 +70%	5 684 +31%	6 313 +11%	5 586 -12%	6 278 +12%	6 604 +5%	6 389 -3%	6 873 +8%	6 765 -2%
Liabilities
Accounts Payable	32	42	36	43	72	52	59	49	100	68	69	87	95	180	185	195	244	324	295	330	342	341	306	262
Accrued Liabilities	35	54	46	31	29	37	45	40	37	70	72	47	69	86	88	104	122	92	71	83	83	79	79	61
Short-Term Debt	101	105	188	129	103	79	172	135	218	380	404	313	120	0	0	3	17	6	11	12	16	33	41	70
Current Portion of Long-Term Debt	0	0	2	0	150	76	8	10	14	16	14	16	0	1	1	0	0	0	25	0	1	1	2	1
Other Current Liabilities	46	22	62	115	78	77	290	274	272	206	172	276	101	167	162	201	678	520	146	254	248	205	412	331
Total Current Liabilities	214	223	334	319	431	321	574	508	641	740	731	739	385	433	435	503	1 061	942	548	680	689	659	840	725
Long-Term Debt	20	20	48	110	20	14	12	10	6	4	2	20	10	0	0	0	3	3	15	0	0	0	3	1
Deferred Income Tax	0	0	0	0	0	0	1	1	1	1	1	1	1	1	1	1	0	10	10	10	10	10	10	9
Minority Interest	1	7	7	2	2	2	11	10	0	6	4	2	0	2	0	3	7	191	222	281	288	277	288	101
Other Liabilities	10	8	8	16	16	0	0	0	0	0	0	46	34	33	46	91	142	136	143	325	344	370	365	614
Total Liabilities	246 N/A	257 +5%	396 +54%	447 +13%	469 +5%	337 -28%	597 +77%	529 -11%	648 +23%	751 +16%	738 -2%	807 +9%	430 -47%	465 +8%	481 +3%	598 +24%	1 213 +103%	1 282 +6%	939 -27%	1 297 +38%	1 332 +3%	1 317 -1%	1 506 +14%	1 450 -4%
Equity
Common Stock	109	109	109	218	218	281	281	281	281	281	281	281	281	286	573	613	899	1 171	1 126	1 126	1 126	1 120	1 120	1 120
Retained Earnings	19	58	65	109	78	111	204	220	258	345	495	583	789	1 115	1 508	1 924	2 487	2 972	2 780	3 119	3 366	3 456	3 673	3 693
Additional Paid In Capital	388	388	388	279	279	215	214	214	212	212	212	212	212	297	50	1 245	1 559	1 310	881	887	893	834	892	765
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20	54
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	64	62	33	475	421	140	150	113	338	338	210
Other Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Equity	516 N/A	556 +8%	562 +1%	607 +8%	575 -5%	606 +5%	698 +15%	714 +2%	751 +5%	838 +12%	988 +18%	1 076 +9%	1 282 +19%	1 633 +27%	2 069 +27%	3 749 +81%	4 471 +19%	5 031 +13%	4 647 -8%	4 982 +7%	5 272 +6%	5 072 -4%	5 367 +6%	5 314 -1%
Total Liabilities & Equity	762 N/A	813 +7%	958 +18%	1 054 +10%	1 044 -1%	943 -10%	1 295 +37%	1 243 -4%	1 399 +13%	1 589 +14%	1 725 +9%	1 883 +9%	1 712 -9%	2 098 +23%	2 550 +22%	4 348 +70%	5 684 +31%	6 313 +11%	5 586 -12%	6 278 +12%	6 604 +5%	6 389 -3%	6 873 +8%	6 765 -2%
Shares Outstanding
Common Shares Outstanding	1 022	1 022	1 022	1 022	1 022	1 022	1 022	1 022	1 022	1 022	1 022	1 022	1 022	1 041	1 043	1 116	1 131	1 143	1 099	1 099	1 120	1 087	1 087	1 120

Income Statement Balance Sheet Cash Flow Statement

Jinyu Bio-Technology Co Ltd
SSE:600201

Balance Sheet

Balance Sheet Decomposition
Jinyu Bio-Technology Co Ltd

Balance Sheet
Jinyu Bio-Technology Co Ltd

See Also

Company

Help

Tools

Stocks

Jinyu Bio-Technology Co Ltd SSE:600201

Balance Sheet

Balance Sheet Decomposition Jinyu Bio-Technology Co Ltd

Balance Sheet Jinyu Bio-Technology Co Ltd

See Also

Company

Help

Tools

Stocks

Jinyu Bio-Technology Co Ltd
SSE:600201

Balance Sheet Decomposition
Jinyu Bio-Technology Co Ltd

Balance Sheet
Jinyu Bio-Technology Co Ltd